Finance
Finance
BerandaBSLN • SWX
Basilea Pharmaceutica AG Allschwil
CHF 54,50
30 Jan, 16.53.25 GMT+1 · CHF · SWX · Pernyataan Penyangkalan
SahamSekuritas terdaftar di CH
Tutup sebelumnya
CHF 54,90
Rentang hari
CHF 54,40 - CHF 55,20
Rentang tahun
CHF 37,50 - CHF 59,70
Kapitalisasi pasar
725,88 jt CHF
Volume Rata-Rata
39,00 rb
Rasio P/E
10,41
Hasil dividen
-
Bursa utama
SWX
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
(CHF)Jun 2025Perubahan Y/Y
Pendapatan
51,98 jt36,26%
Biaya operasional
8,53 jt13,23%
Penghasilan bersih
7,90 jt-23,80%
Margin laba bersih
15,20-44,08%
Penghasilan per saham
——
EBITDA
12,55 jt147,17%
Tarif pajak efektif
18,31%—
Total aset
Total liabilitas
(CHF)Jun 2025Perubahan Y/Y
Investasi tunai jangka pdk
128,36 jt103,87%
Total aset
248,85 jt31,90%
Total liabilitas
145,69 jt-15,24%
Total ekuitas
103,16 jt—
Saham yang beredar
12,28 jt—
Harga terhadap nilai buku
6,54—
Tingkat pengembalian aset
12,25%—
Tingkat pengembalian modal
15,24%—
Perubahan kas bersih
(CHF)Jun 2025Perubahan Y/Y
Penghasilan bersih
7,90 jt-23,80%
Kas dari operasi
11,53 jt28,66%
Kas dari investasi
-207,00 rb-258,62%
Kas dari pembiayaan
-7,24 jt-10,11%
Perubahan kas bersih
4,08 jt58,53%
Arus kas bebas
8,89 jt135,55%
Tentang
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
Didirikan
2000
Karyawan
180
Telusuri
Hapus penelusuran
Tutup penelusuran
Aplikasi Google
Menu utama